EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Prostate cancer stem cells and their targeted therapies

Huilan Su, Liqun Huang, Jianjun Zhou, Guosheng Yang

Frontiers in Cell and Developmental Biology · 08.08.2024 · 12

DOI: 10.3389/fcell.2024.1410102 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 08.08.2024. Verfasst von Huilan Su und 3 weiteren Autor:innen. Beteiligte Einrichtung: Research Center for Translational Medicine, Cancer Stem Cell Institute, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 132 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Prostate cancer (PCa) is the most common malignancy among men worldwide. Through androgen receptor signaling inhibitor (ARSI) treatment, patients eventually succumb to castration-resistant prostate cancer (CRPC). For this, the prostate cancer stem cells (PCSCs), as a minor population of tumor cells that can promote tumor relapse, ARSI resistance, and disease progression, are gaining attention. Therefore, specific therapy targeting PCSCs has momentum. This study reviewed the identification and characterization of PCSCs and PCSC-based putative biomarkers and summarized their mechanisms of action. We further discussed clinical trials of novel therapeutic interventions focused on PCSC-related pathways, the PCSC microenvironment, cutting-edge miRNA therapy, and immunotherapy approaches from a mechanistic standpoint. This review provides updated insights into PCSC plasticity, identifying new PCSC biomarkers and optimized treatments for patients with advanced PCa.

Schlagwörter

Stichwörter der Autor:innen

basal progenitor cellsluminal progenitor cellsprostate cancerprostate cancer stem cellstargeted therapy

Autor:innen und Institutionen

  • Research Center for Translational Medicine, Cancer Stem Cell Institute, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.
  • Department of Urology, Shanghai East Hospital, Tongji University School of Medicine, Shanghai, China.

Zitieren

APA

Su, H., Huang, L., Zhou, J., & Yang, G. (2024). Prostate cancer stem cells and their targeted therapies. Frontiers in Cell and Developmental Biology, 12. https://doi.org/10.3389/fcell.2024.1410102

Vancouver

Su H, Huang L, Zhou J, Yang G. Prostate cancer stem cells and their targeted therapies. Frontiers in Cell and Developmental Biology. 2024;12. doi:10.3389/fcell.2024.1410102

BibTeX
@article{Su2024,
  author = {Su, Huilan and Huang, Liqun and Zhou, Jianjun and Yang, Guosheng},
  title = {Prostate cancer stem cells and their targeted therapies},
  journal = {Frontiers in Cell and Developmental Biology},
  year = {2024},
  volume = {12},
  doi = {10.3389/fcell.2024.1410102}
}
Kostenlos starten →